CInacalcet is used to treat elevated parathyroid hormone conditions.
| Mimpara Brand |
30mg 28 Tablets |
$445.00 | ||
| Mimpara Brand |
60mg 28 Tablets |
$834.00 | ||
| Mimpara Brand |
90mg 28 Tablets |
$1,239.00 |
Mimpara is an agent that increases the sensitivity of the parathyroid gland to calcium in the body. This causes a decrease in levels of parathyroid hormone (PTH), calcium, and phosphorous in the body. Cinacalcet is used to reduce elevated levels of parathyroid hormone (PTH) in people with chronic renal disease who are on dialysis. Sensipar (Cinacalcet) is also used to lower calcium levels in patients with cancer of the parathyroid gland.
Send Your Prescription
No Hidden Fees
Typically Under 7 days
Are you wondering which drugs are most popular on the IsraelPharm website? Maybe you or someone you know is looking for an alternative source for your prescriptions meds? then read on if you’re curious about
Acne can be more than a teenage nightmare. There’s a common misconception that pimples are a transient plague that should disappear as you pass through the hormonal firestorm brought on by puberty. However, there can
We wanted to share something with you, something that is not widely known to many Americans (and not all Israeli’s either). In Israel we have a dedicated memorial to the terrorist attack of 9/11. Not
An aching head is something that many people will experience occasionally. There are no clear boundaries that can distinguish between a transient headache that has minimal clinical importance, and that will clear up without radical
When planning to pack for your summer holiday there are always things that get pushed off until the last minute or forgotten about entirely. Don’t let your medical needs be the last thing on your
If you are currently being treated for osteoporosis with Prolia, the February 2023 issue of the Journal of the American Board of Family Medicine contained a study that could cause your healthcare provider to recommend
In May 2023, the FDA allowed the treatment of heart failure with Farxiga (dapagliflozin), a sodium-glucose cotransporter 2 (SGLT2) inhibitor. The first SGLT2 inhibitor to be FDA-approved was Invokana (canagliflozin) in March 2013, followed by
It is part of “folk lore” that as men grow older, they become much more susceptible to heart problems. There is little doubt that people believe that men are more likely to develop serious heart
